SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NPSP NPS Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (326)4/14/2010 1:17:04 PM
From: tuck  Read Replies (1) | Respond to of 363
 
We are now looking at early 2012 for Gattex launch, with money sufficient only to next year. Nevertheless, stock is near highs after a Needham upgrade, with target of $9. Best case scenario is good results late this year, THEN the financing.

streetinsider.com

Cheers, Tuck



To: tuck who wrote (326)3/28/2011 1:41:26 PM
From: tuck  Respond to of 363
 
Nycomed files for EU approval of GATTEX, reportedly triggering a "mid seven figure" milestone payment.

npsp.com

Cheers, Tuck